Long-term use of combined radiation therapy and hormonal therapy in the management of stage D1 prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 5, 2002, Pages 1146-1151

  Robnett, Theodore J ^a   Whittington, Richard ^b   Malkowicz, S Bruce ^b   Brereton, Harmar D ^c   Van Arsdalen, Keith ^b   Drach, George ^b   Wein, Alan J ^b  

^a Radiological Associates of Sacramento Medical Group Inc   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c Mercy Hospital   (United States)

Author keywords

Hormonal therapy; Metastatic adenopathy; Prostate cancer; Radiation therapy

Indexed keywords

BIOPSY; HORMONES; PATIENT TREATMENT; RADIOGRAPHY; TUMORS;

HORMONAL THERAPY; MULTIVARIATE ANALYSIS;

RADIOTHERAPY;

ANTIANDROGEN; DIETHYLSTILBESTROL; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORCHIECTOMY; PATHOLOGY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIOGRAPHY; RECTUM FISTULA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY; URETER FISTULA;

AGED; DISEASE-FREE SURVIVAL; HORMONES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036680146     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02868-7     Document Type: Article

References (24)

1. Cancer statistics, 2001
2. Prognosis of patients with stage D1 prostatic adenocarcinoma
3. Extended field radiation therapy versus delayed hormonal therapy in node positive prostate cancer
4. Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation
5. Results of conservative management of clinically localized prostate cancer
6. A decision analysis of alternative treatment strategies for clinically localized prostate cancer
7. Prognostic factors in stage D1 prostate cancer: Identification of patients less likely to have prolonged survival after radical prostatectomy
8. Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy
9. Progression in untreated carcinoma of the prostate metastatic to regional lymph nodes (stage T0 to 4, N1 to 3, M0, D1)
10. The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer
11. Combined hormonal and radiation therapy for lymph node-positive prostate cancer
12. Nonparametric estimation from incomplete observations
13. Evaluation of survival data and two new rank order statistics arising in the consideration
14. Regression models and life tables
15. Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?
16. Stage T1-2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy
17. Lymph node-positive prostate cancer: Evaluation of the results of the combination of androgen deprivation therapy and radiation therapy
18. Androgen regulation of programmed cell death of normal and malignant prostatic cells
19. Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study
20. A phase III trial of total androgen suppression versus total androgen suppression plus definitive external beam irradiation for pathologic lymph node positive (pN+) adenocarcinoma of the prostate
21. An evaluation of lymphography with nodal biopsy in localized carcinoma of the prostate
22. The accuracy of CT in the staging of carcinoma of the prostate